Neoadjuvant Docetaxel in Treating Women With Newly Diagnosed Breast Cancer

NCT00080626 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

19

Enrollment

OTHER

Sponsor class

Stopped low accrual

Conditions

Breast Cancer

Interventions

BIOLOGICAL: pegfilgrastim
DRUG: docetaxel
PROCEDURE: conventional surgery
PROCEDURE: neoadjuvant therapy

Sponsor

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Collaborators

[object Object]